The AAP and Dr. Tayloe: Ignoring a generation of sick kids Age of Autism, Trumbull - Nov 13, 2008 Tayloe said that he intends to focus on 5 main areas this coming year -- "Medicaid payments, vaccine financing issues, fair payment of pediatricians, ...
Merck's 2008: The Year That Wasn't Trading Markets (press release), CA - Nov 19, 2008 Expanding the vaccine's indication is one sure-fire way to increase sales. Another promising drug in Merck's roster is Januvia, which is used to treat type ...MRK
Change your lifestyle Hindu, India - Nov 8, 2008 Childhood obesity is a major worldwide epidemic. The consequence of overweight and obesity among children will be the development of Type 2 diabetes in ...
Food Allergy on the Rise, New Treatments on the Horizon Newswise (press release) - Nov 10, 2008 Food consumption and obesity, including the highly allergenic foods: fish, peanut, tree nuts, milk, egg and soy. ? Eating out, and the prevalence of buffet ...
Oncophage disappoints ecancermedicalscience, UK - The study, published in the Lancet July 3 rd , was the largest to date, showed a disappointing turn from oncophage?s seemingly promising performance in ...
HIV vaccine 'allows drug breaks' BBC News, UK - Aug 4, 2008 The vaccine, which works by stimulating an immune system response, has already been tested in two small trials on 11 and 38 HIV patients with promising...
Search this blog ScienceBlogs - She wanted to know why making an HIV-1 vaccine was so hard (seriously, why could they make a polio vaccine 60 years ago, and we cant do the same thing with ...
Meningitis B vaccine looks promising T Sheldon - BMJ: British Medical Journal, 1998 - pubmedcentral.nih.gov 1998 September 19; 317(7161): 770. Copyright ? 1998, British Medical Journal.
Meningitis B vaccinelookspromising. Tony Sheldon. ...
New hope for vaccine against schistosomiasis - J Cherfas - Science, 1991 - sciencemag.org ... Though Capron's candidate vaccine is closest to human trials, several other groups
are reporting promising results from alter- native strategies. ...
Treatment options for chronic hepatitis: Antivirals look promising - AJ Zuckerman, D Lavanchy - BMJ: British Medical Journal, 1999 - pubmedcentral.nih.gov ... Antivirals lookpromising. AJ Zuckerman, director World Health Organisation ... clinical
trial results are promising, there is a ... being used to reduce vaccine costs. ...
[PDF]The search for effective HIV vaccines - H Markel - N Engl J Med, 2005 - tokb.ru ... transmits the HIV genes gag, pol, and nef (which code for internal HIV proteins
and may stimulate cellular im- munity); this vaccinelooks far more promising. ... -
Human cytomegalovirus vaccine: time to look for alternative options - R Khanna, DJ Diamond - Trends in Molecular Medicine, 2006 - Elsevier ... Human cytomegalovirus vaccine: time to look for alternative ... Subsequently, delivery
of gB vaccine in live viral ... and pox virus), showed some promising results in ...
Correlates of Protective Immunity to Mycobacterium tuberculosis in Humans - JJ Ellner, CS Hirsch, CC Whalen - Clinical Infectious Diseases, 2000 - UChicago Press ... vaccines to demonstrate that they are modulated by the vaccine under study ... of the
?half-steps.? Ultimately, an assay that lookspromising from multiple ...
[CITATION]Vaccine update: Group B streptococcal vaccine looks promising A Gershon - 1999 - Infectious Disease Society of America-37th Annual Meeting, Day
MONDAY, July 31 (HealthDay News) -- Researchers are reporting progress toward what would be a dream come true for many Americans: a vaccine to prevent obesity.
The target of this vaccine is ghrelin, a recently discovered hormone that decreases energy expenditure and fat breakdown. Scientists at the Scripps Research Institute in California reported in this week's issue of the Proceedings of the National Academy of Sciences that they have developed a way to make the immune system produce antibodies that attack ghrelin, and that rats given the vaccine ate normally but lost weight.
"We have enabled the immune system to recognize a molecule that it ordinarily won't recognize," explained study author Kim D. Janda, a professor of chemistry at Scripps.
The immune system thus produced antibodies that bound to and deactivated ghrelin, just as vaccines against diseases caused by bacteria or viruses bind to and inactivate them.
Mice given shots of the vaccine ate just as much as untreated mice but had "about a 20 or 30 percent reduction in weight gain," Janda said.
However, the mice were fed low-fat, low-energy diets. It's not certain that a ghrelin vaccine would be effective against the burger-rich, high-fat diet that many Americans eat, the researchers noted.
This is not the only effort to develop a vaccine against ghrelin, the Scripps researchers added. Cytos, a Swiss-based biotechnology company, is already testing a different vaccine in humans. It works in a different way than the Scripps vaccine, by preventing the uptake of ghrelin by the brain.
A lot of basic work must be done before the Scripps obesity vaccine will be tried in humans, Janda said. "We're going to look at some different flavors of antibodies, see how they work, and then try them in animals," he said.
Caution will be the byword, Janda said. "We want to do real basic work and make sure we do all our homework before we look at it in humans," he stressed. "We could do it quickly, but it's prudent to know exactly what's going on."
His best guess is that a first human trial is "about two years" away. The Scripps group is looking to link up with a major pharmaceutical company to help develop a usable vaccine, Janda said.
It's too early to say how such a vaccine would be given, he said. "It depends on what kind of vaccine it is," Janda said. "It could be given just once or it could be multiple shots."
And shots might not even be necessary. There could be an oral vaccine, of the same type as developed for polio and other disease, Janda said.
Dr. David E. Cummings, an associate professor of medicine at the University of Washington, did early work showing that ghrelin levels rise before each meal. He said the new study goes a long way toward showing that a ghrelin vaccine could reduce weight gain.
The one doubt about ghrelin has been whether its removal would affect weight gain, Cummings said. The weight loss in animals bred to lack the ghrelin gene has been "very subtle," he said, raising doubts about the value of an attack on ghrelin.
"The potential value of this study is that it answers the question, 'What if you remove ghrelin from an adult animal?' " Cummings said. "This paper shows that it does affect weight."